| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.00396 (Beat by $0.01396) |
| EPS GAAP Actual | $0.00396 (Beat by $0.01396) |
| Revenue Actual | $0.0473163B |
| Revenue Surprise | Beat by $47.3163M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.053B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.19 | 3.36 | 0.18837 | 0.19183 | 1 |
| Dec 2028 | 0.12 | 5.31 | 0.11897 | 0.12116 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.004 | -0.016 | 0.0473163B | 13.37% | -4.68M |
| FQ4 2008 (Oct 2008) | -96674 | -96674 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | -0.0018 | -0.0018 | 0.0427231B | 24.79% | 34.68M |
| FQ2 2025 (Jun 2025) | -0.026 | -0.046 | 0.0432454B | 8.86% | -7.75M |
| FQ4 2023 (Oct 2023) | 0 | -2.08841 | 0.011781B | 100% | 0.78M |
| FQ1 2024 (Mar 2024) | 0.0199 | 0.0199 | 0.0321329B | 100% | 32.13M |
| FQ2 2024 (Jun 2024) | 0.0005 | -0.0095 | 0.0394152B | 100% | -5.33M |
| FQ3 2024 (Sep 2024) | -0.03 | -1.57141 | 0.0409923B | 72.42% | -0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.053B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.05 | -- | 0.04705643 | 0.05294358 | 1 |
| FQ3 2026 (Sep 2026) | 0.04 | 90 | 0.04 | 0.04 | 1 |
| FQ2 2026 (Jun 2026) | 0.04 | 165 | 0.04 | 0.04 | 1 |
| FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.07B | -- | 0.06B | 0.07B | 1 |
| FQ3 2026 (Sep 2026) | 0.06B | 24.89 | 0.06B | 0.06B | 1 |
| FQ2 2026 (Jun 2026) | 0.06B | 31.36 | 0.06B | 0.06B | 1 |
| FQ1 2026 (Mar 2026) | 0.05B | 19.39 | 0.05B | 0.05B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
4
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.02 | 0.004 | -0.016 | -400% |
| FQ4 2008 (Oct 2008) | -96674 | -96674 | 100% | |
| FQ1 2025 (Mar 2025) | 0 | -0.0018 | -0.0018 | 100% |
| FQ2 2025 (Jun 2025) | 0.02 | -0.026 | -0.046 | 176.92% |
| FQ4 2023 (Oct 2023) | 2.08841 | 0 | -2.08841 | -INF% |
| FQ1 2024 (Mar 2024) | 0.0199 | 0.0199 | 100% | |
| FQ2 2024 (Jun 2024) | 0.01 | 0.0005 | -0.0095 | -1900% |
| FQ3 2024 (Sep 2024) | 1.54141 | -0.03 | -1.57141 | 5238.03% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.05B | $0.05B | $-4.68M | -9.9% |
| FQ4 2008 (Oct 2008) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0.01B | $0.04B | $34.68M | 81.18% |
| FQ2 2025 (Jun 2025) | $0.05B | $0.04B | $-7.75M | -17.93% |
| FQ4 2023 (Oct 2023) | $0.01B | $0.01B | $0.78M | 6.63% |
| FQ1 2024 (Mar 2024) | $0B | $0.03B | $32.13M | 100% |
| FQ2 2024 (Jun 2024) | $0.04B | $0.04B | $-5.33M | -13.51% |
| FQ3 2024 (Sep 2024) | $0.04B | $0.04B | $-0M | -0% |